Just one pot of cash

July 30, 2004

Your report "Bypass fear for clinical funding" (July 16) gave the misleading impression that the Medical Research Council has separate pots of money for "clinical" and "other" research, and that we will be forced to plunder the latter to meet the aims of the new joint MRC-Department of Health Delivery Group.

For nearly a century, our research has been key to delivering our mission to improve human health. Good medical research relies on the seamless blend of basic, clinical and population approaches. The MRC therefore invests in relevant biomedical science, from molecular and cellular research through to clinical trials.

The MRC continues to face tough decisions about funding across the whole portfolio. Drawing on high-quality peer-review, and setting strategic priorities through advice from our many stakeholders, including the research community and the health departments, we aim to continue to fund the highest quality science to benefit public health.

Colin Blakemore
Chief Executive, MRC

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments